Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1
暂无分享,去创建一个
K. Ushijima | H. Yoshikawa | I. Konishi | T. Kamura | T. Shibata | S. Nishio | R. Kitagawa